Par reports higher net income
-
- November
- 21
Par Pharmaceutical Co. Inc., which has research and manufacturing operations in Chestnut Ridge, yesterday reported net income of $37.4 million, or $1.07 per share, during the first six months of 2007, compared to net income of $6.6 million, or 19 cents per share, a year earlier, after adjusting for special items. Revenues of $401.9 million rose from $367.6 million a year earlier. Par said that it included the results in a filing with the the U.S. Securities and Exchange Commission that had been delayed due to restating its consolidated financial statements.
This entry was posted
on Wednesday, November 21st, 2007 at 6:27 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy:
|
Print
|
Email
Leave a Reply
It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the
Terms of Service.